Recent Advances across Genetic Discoveries

USD 250

* Required Fields

USD 250


Be the first to review this product

With the increase in gene-based technologies such as gene regulation and gene editing, there have been a number of recent discovers across genetic technologies. Currently, there is keen interest toward developing novel treatments based on genes that have been discovered to have a major linkage to the development and progression of certain rare diseases. A prominent rare disease that is being actively researched is the Fragile X Syndrome. There are also a range of companies that have successfully utilized gene editing techniques to develop diseases resistance in mammalian species. Such gene editing techniques could revolutionize the manner in which human diseases can be cured in the near future.

The Genetic Technology TechVision Opportunity Engine (TOE) presents the latest R&D developments and advances with an emphasis on opportunities to profit in the explosive field of genetic technology through technology transfer, joint ventures, and acquisitions. The complete gamut of genetic technology applications is covered including the latest developments in omics technologies; genetic, cellular, and alternative therapies; sequencing technologies; and genetically altered animals and plants.

The Health & Wellness cluster tracks developments in a myriad of areas including genetic engineering, regenerative medicine, drug discovery and development, nanomedicine, nutrition, cosmetic procedures, pain and disease management and therapies, drug delivery, personalized medicine, and smart healthcare.

Keywords: Gene editing technique, gene regulation, genetic technologies, Fragile X Syndrome, rare genetic diseases, hybrid embryos, pig chimera, CRISPR

Table of Contents

Recent Advances across Genetic DiscoveriesTechnology ProfilesResearch Enables Possibility of Transplantable Human Organ Growth In AnimalsGene Editing Enables Cows to Gain Resistance to TuberculosisTool for Better Understanding of Disease MechanismsType 2 Diabetes Treatment with Novel Gene DiscoveryAppendixClinical Trial AnalysisIndustry Interactions




Related Research

Release Date : 15-Dec-17

Region : Global

Release Date : 08-Dec-17

Region : Global

Release Date : 08-Dec-17

Region : Global

Release Date : 01-Dec-17

Region : Global

Release Date : 29-Nov-17

Region : Global

Related Subscription

• One-2-One Analyst briefing call •
• Access to published and new research deliverables •
• Mid year service review •
• Virtual Analyst briefing •
• GIL conference seats •

Why Frost & Sullivan

Working with the CEO’s growth team to create a vision based on a transformation growth strategy

Creating content-based digital marketing strategies that leverage our research perspective to differentiate and “tell your story”

Tracking over 1000 emerging technologies and analyzing the impact by industry and application to reveal the companies to watch in each sector

The Frost & Sullivan team is based in our 45 global offices and have developed a powerful global understandings of how industries operate on a global level.